ONO PHARMACEUT.OO

ONO PHARMACEUT.

10.0EURD
−0.1−0.99%
At close at Mar 4, 21:59 GMT
EUR
No trades
See on Supercharts

ON4 fundamentals

ONO PHARMACEUT. earnings per share and revenue

ON4 earnings per share for the last quarter are 0.20 EUR whereas the estimation was 0.26 EUR which accounts for -23.96% surprise. Company revenue for the same period amounts to 824.62 M EUR despite the estimated figure of 805.48 M EUR. Estimated earnings per share for the next quarter are 0.15 EUR, and revenue is expected to reach 774.84 M EUR. Also watch annual changes over time to get a bigger picture of ON4 earnings per share and revenue dynamics.

Next report date
≈ 
Report periodQ4 2024
EPS estimate0.14EUR
Revenue estimate‪763.05 M‬EUR
EPS
Forecast
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪0.16‬
‪0.32‬
‪0.48‬
‪0.64‬
Reported
Estimate
Currency: EUR
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
‪0.33‬
‪0.41‬
‪0.56‬
‪0.49‬
‪0.29‬
‪0.31‬
‪0.22‬
‪0.20‬
Estimate
‪0.31‬
‪0.44‬
‪0.61‬
‪0.47‬
‪0.31‬
‪0.31‬
‪0.32‬
‪0.26‬
‪0.14‬
‪0.20‬
Surprise
+8.19%
−5.42%
−8.78%
+3.68%
−7.76%
−1.89%
−29.02%
−23.96%
Revenue
Forecast
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪250.00 M‬‬
‪‪500.00 M‬‬
‪‪750.00 M‬‬
‪‪1.00 B‬‬
Reported
Estimate
Currency: EUR
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
‪‪751.21 M‬‬
‪‪762.30 M‬‬
‪‪878.03 M‬‬
‪‪842.36 M‬‬
‪‪737.83 M‬‬
‪‪682.46 M‬‬
‪‪766.45 M‬‬
‪‪824.62 M‬‬
Estimate
‪‪771.96 M‬‬
‪‪746.67 M‬‬
‪‪806.92 M‬‬
‪‪969.26 M‬‬
‪‪754.47 M‬‬
‪‪656.94 M‬‬
‪‪789.55 M‬‬
‪‪805.48 M‬‬
‪‪763.05 M‬‬
‪‪825.95 M‬‬
Surprise
−2.69%
+2.09%
+8.81%
−13.09%
−2.21%
+3.89%
−2.93%
+2.38%